ZOPOLRESTAT

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H12F3N3O3S
Molecular Weight	419.377
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of ZOPOLRESTAT

Structure Search

SMILES

OC(=O)CC1=NN(CC2=NC3=CC(=CC=C3S2)C(F)(F)F)C(=O)C4=CC=CC=C14

InChI

InChIKey=BCSVCWVQNOXFGL-UHFFFAOYSA-N

InChI=1S/C19H12F3N3O3S/c20-19(21,22)10-5-6-15-14(7-10)23-16(29-15)9-25-18(28)12-4-2-1-3-11(12)13(24-25)8-17(26)27/h1-7H,8-9H2,(H,26,27)

HIDE SMILES / InChI

Molecular Formula	C19H12F3N3O3S
Molecular Weight	419.377
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Sat Dec 16 05:18:14 UTC 2023` Edited by `admin` on `Sat Dec 16 05:18:14 UTC 2023`
Record UNII	1PV3S9WP3D
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ZOPOLRESTAT

Official Name

English

zopolrestat [INN]

Common Name

English

3,4-Dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid

Systematic Name

English

ZOPOLRESTAT [USAN]

Common Name

English

ZOPOLRESTAT [MI]

Common Name

English

1-PHTHALAZINEACETIC ACID, 3,4-DIHYDRO-4-OXO-3-((5-(TRIFLUOROMETHYL)-2-BENZOTHIAZOLYL)METHYL)-

Common Name

English

ALOND

Brand Name

English

Zopolrestat [WHO-DD]

Common Name

English

CP-73850

Code

English

CP-73,850

Code

English

Classification Tree Code System Code

NCI_THESAURUS

C72880

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

Code System Code Type Description

MESH

C067172

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

INN

6740

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

EVMPD

SUB00189MIG

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

USAN

CC-37

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

ChEMBL

CHEMBL10372

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

NCI_THESAURUS

C82174

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

PUBCHEM

1613

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

MERCK INDEX

m11664

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

Merck Index

SMS_ID

100000078819

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

FDA UNII

1PV3S9WP3D

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

CAS

110703-94-1

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

EPA CompTox

DTXSID80149365

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

DRUG BANK

DB08772

Created by admin on Sat Dec 16 05:18:14 UTC 2023 , Edited by admin on Sat Dec 16 05:18:14 UTC 2023

PRIMARY

Related Record Type Details


					73C27N6Z7U

ALDOSE REDUCTASE

TARGET -> INHIBITOR

Comments:

Inactive Indications on highest development phases; Discontinued : Diabetic cardiomyopathy; Diabetic nephropathies; Diabetic neuropathies

Related Record Type Details


					1PV3S9WP3D

ACTIVE MOIETY